Clinical Trials Directory

Trials / Unknown

UnknownNCT02476149

Biomechanical Properties of Keratoconic Eyes

Status
Unknown
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
University of Plymouth · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In keratoconus (KC) corneal thinning and protrusion can cause myopia and irregular astigmatism, affecting vision. The biomechanical properties of the cornea is maintained by an intricate collagen network, which is responsible for its shape and function. In KC this collagen network is disrupted resulting in the cornea losing its shape and function. Keratoconic changes are focal and localised to certain regions of the cornea and the early detection of these changes is challenging. Screening methods include corneal topography (evaluation of anterior corneal surface curvature), tomography (assessing the morphological features of the anterior segment) and aberrometry (measuring the optical aberrations of the eye). More recent research suggests that the biomechanical destabilization of the cornea may precede topographic and tomographic evidence of KC. Management of KC depends on disease severity with severe cases being treated with keratoplasty and less severe cases with cornealcollagencrosslinking (CXL). CXL is an emerging technique, which aims to increase the biomechanical strength of the keratoconic cornea. Despite strong evidence of changes in the biomechanical properties in human corneas following CXL, there is a significant need for accurate measures of biomechanical changes in vivo pre and post CXL. Until recently technical limitations have restricted the ability to assess the biomechanical properties of the whole cornea in vivo. With the introduction of the CorvisST (Oculus) it is now possible to assess regional biomechanical behaviour of the cornea. The output from the device provides a variety of parameters to indicate the cornea's biomechanical strength. To date, the association between the deflection behaviours in various regions of the cornea in keratoconic eyes preand post CXL has not been studied. In order to effectively assess the clinical benefits of CXL such information is vital. The primary goal of this investigation is to investigate regional biomechanical properties of the keratoconic eye before and after CXL.

Conditions

Interventions

TypeNameDescription
PROCEDURECorneal Cross-linkingAll participants recruited for the study will be scheduled for corneal crosslinking treatment

Timeline

Start date
2015-06-01
Primary completion
2019-12-01
Completion
2020-01-01
First posted
2015-06-19
Last updated
2019-01-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02476149. Inclusion in this directory is not an endorsement.